Wako, Japan

Atsuko Sakai

This inventor holds 4 USPTO granted patents. Top assignees: Mitsubishi Tanabe Pharma Corporation, Tanabe Seiyaku Company, Limited. Active years: 2006-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsuko Sakai. Retrieved from https://idiyas.com/inventor/atsuko-sakai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2006-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Atsuko Sakai: Innovator in Pharmaceutical Chemistry

Introduction

Atsuko Sakai is a prominent inventor based in Wako, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 4 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest innovations are condensed polycyclic compounds. These compounds are recognized for their utility as phosphodiesterase 4 inhibitors. The invention provides a novel condensed polycyclic compound, which is represented by a specific formula or a pharmaceutically acceptable salt thereof, along with a pharmaceutical composition containing the same.

Career Highlights

Atsuko has worked with notable companies in the pharmaceutical industry, including Mitsubishi Tanabe Pharma Corporation and Tanabe Seiyaku Company, Limited. Her experience in these organizations has allowed her to contribute to various projects and advancements in drug development.

Collaborations

Throughout her career, Atsuko has collaborated with esteemed colleagues such as Tatsuzo Ukita and Yoshihiro Terakawa. These partnerships have further enriched her research and innovation efforts.

Conclusion

Atsuko Sakai stands out as a dedicated inventor whose work in condensed polycyclic compounds has the potential to impact pharmaceutical therapies significantly. Her contributions continue to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…